Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Academia and Government
June 25, 2017
Life Sciences and Healthcare
June 22, 2017
Academia and Government
June 19, 2017
Academia and Government
June 15, 2017
Academia and Government
June 14, 2017
Life Sciences and Healthcare
June 12, 2017